Stelmakh Edward 4
4 · OptimizeRx Corp · Filed Oct 15, 2024
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Stelmakh Edward
CFO/COO
Transactions
- Exercise/Conversion
Common Stock
2024-10-11+8,222→ 35,432 total - Tax Payment
Common Stock
2024-10-11$6.63/sh−2,066$13,698→ 33,366 total - Exercise/Conversion
Restricted Stock Units
2024-10-11−8,222→ 0 total→ Common Stock (8,222 underlying)
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
- [F3]The restricted stock units vest in three equal annual installments beginning October 11, 2022, the first anniversary of the grant date.